Figure 2

Morphology of HEK293 cells in absence and presence of ORF3a inhibitors. (A) HEK293 cells transfected with empty pRK vector. (B–C): HEK293 cells transfected with ORF3a. (B) untreated; (C) treated with 6-gingerol (inactive against ORF3a); (D) treated with EGCG (active ORF3a inhibitor).